Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3814566
Max Phase: Preclinical
Molecular Formula: C26H37N5O7
Molecular Weight: 531.61
Molecule Type: Small molecule
Associated Items:
ID: ALA3814566
Max Phase: Preclinical
Molecular Formula: C26H37N5O7
Molecular Weight: 531.61
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)/C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1cc(C)on1)C(C)C
Standard InChI: InChI=1S/C26H37N5O7/c1-5-37-21(32)9-8-18(14-17-10-11-27-23(17)33)28-25(35)20-7-6-12-31(20)26(36)22(15(2)3)29-24(34)19-13-16(4)38-30-19/h8-9,13,15,17-18,20,22H,5-7,10-12,14H2,1-4H3,(H,27,33)(H,28,35)(H,29,34)/b9-8+/t17-,18+,20-,22-/m0/s1
Standard InChI Key: CDLJCDVOUXXTCZ-MOWRWRMQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 531.61 | Molecular Weight (Monoisotopic): 531.2693 | AlogP: 0.86 | #Rotatable Bonds: 11 |
Polar Surface Area: 159.94 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.46 | CX Basic pKa: | CX LogP: 0.53 | CX LogD: 0.53 |
Aromatic Rings: 1 | Heavy Atoms: 38 | QED Weighted: 0.28 | Np Likeness Score: -0.46 |
1. Kawatkar SP, Gagnon M, Hoesch V, Tiong-Yip C, Johnson K, Ek M, Nilsson E, Lister T, Olsson L, Patel J, Yu Q.. (2016) Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease., 26 (14): [PMID:27265257] [10.1016/j.bmcl.2016.05.066] |
Source(1):